Cefpodoxime Proxetil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 256 publications
What Makes Cefpodoxime an Empiric Drug of Choice to Treat Lower Respiratory Tract Infections, including Acute Exacerbation of Chronic Obstructive Pulmonary Disease, in the Real-world Setting in India?
Journal: The Journal of the Association of Physicians of India
Published: October 16, 2025
Comparative efficacy and safety of co-amoxiclav, cefpodoxime proxetil, and levofloxacin in patients with acute uncomplicated bacterial tonsillitis: A prospective, open-label, parallel group study.
Journal: Journal of family medicine and primary care
Published: April 25, 2024
Lab on chip based self-adjustable liposomes for rapid wound healing: An in depth in vitro, in vivo and higher dose toxicity investigation.
Journal: Biomaterials advances
Published: November 20, 2023
HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.
Journal: Journal of Taibah University Medical Sciences
Published: June 03, 2023
Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs.
Journal: Frontiers in veterinary science
Published: September 20, 2022
Cephalosporin as Potent Urease and Tyrosinase Inhibitor: Exploration through Enzyme Inhibition, Kinetic Mechanism, and Molecular Docking Studies.
Journal: BioMed research international
Published: June 25, 2022
Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data.
Journal: Antibiotics (Basel, Switzerland)
Published: March 09, 2022
Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.
Journal: Acta biomaterialia
Published: December 27, 2021
Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
Journal: Drug development and industrial pharmacy
Published: October 04, 2021
Study of the structure and dynamics at various parts of the antibacterial drug molecule cefpodoxime proxetil.
Journal: Solid state nuclear magnetic resonance
Published: May 25, 2021
Interactions of the Diazabicyclooctane Serine β-Lactamase Inhibitor ETX1317 with Target Enzymes.
Journal: ACS infectious diseases
Published: December 10, 2020
Last Updated: 04/28/2026